BOEING CO/THE (BCO.DE) Fundamental Analysis & Valuation

FRA:BCO • US0970231058

Current stock price

179.4 EUR
-3.2 (-1.75%)
Last:

This BCO.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BCO.DE Profitability Analysis

1.1 Basic Checks

  • BCO had negative earnings in the past year.
  • BCO had a positive operating cash flow in the past year.
  • BCO had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: BCO reported negative operating cash flow in multiple years.
BCO.DE Yearly Net Income VS EBIT VS OCF VS FCFBCO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B

1.2 Ratios

  • BCO has a Return On Assets of 1.12%. This is in the lower half of the industry: BCO underperforms 69.64% of its industry peers.
  • BCO has a Return On Equity of 34.65%. This is amongst the best in the industry. BCO outperforms 87.50% of its industry peers.
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROIC N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BCO.DE Yearly ROA, ROE, ROICBCO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K

1.3 Margins

  • The Profit Margin of BCO (2.11%) is worse than 67.86% of its industry peers.
  • BCO has a worse Gross Margin (4.79%) than 82.14% of its industry peers.
  • In the last couple of years the Gross Margin of BCO has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 2.11%
GM 4.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
BCO.DE Yearly Profit, Operating, Gross MarginsBCO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. BCO.DE Health Analysis

2.1 Basic Checks

  • BCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BCO has been increased compared to 1 year ago.
  • The number of shares outstanding for BCO has been increased compared to 5 years ago.
  • The debt/assets ratio for BCO has been reduced compared to a year ago.
BCO.DE Yearly Shares OutstandingBCO.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
BCO.DE Yearly Total Debt VS Total AssetsBCO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • Based on the Altman-Z score of 1.32, we must say that BCO is in the distress zone and has some risk of bankruptcy.
  • BCO's Altman-Z score of 1.32 is on the low side compared to the rest of the industry. BCO is outperformed by 82.14% of its industry peers.
  • A Debt/Equity ratio of 8.37 is on the high side and indicates that BCO has dependencies on debt financing.
  • With a Debt to Equity ratio value of 8.37, BCO is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACCN/A
WACC9.49%
BCO.DE Yearly LT Debt VS Equity VS FCFBCO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • BCO has a Current Ratio of 1.19. This is a normal value and indicates that BCO is financially healthy and should not expect problems in meeting its short term obligations.
  • BCO has a Current ratio (1.19) which is comparable to the rest of the industry.
  • BCO has a Quick Ratio of 1.19. This is a bad value and indicates that BCO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.40, BCO is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.4
BCO.DE Yearly Current Assets VS Current LiabilitesBCO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BCO.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 49.34% over the past year.
  • Looking at the last year, BCO shows a very strong growth in Revenue. The Revenue has grown by 34.50%.
  • BCO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.81% yearly.
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%

3.2 Future

  • BCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.39% yearly.
  • The Revenue is expected to grow by 9.67% on average over the next years. This is quite good.
EPS Next Y103.37%
EPS Next 2Y56.63%
EPS Next 3Y41.46%
EPS Next 5Y26.39%
Revenue Next Year10%
Revenue Next 2Y12.26%
Revenue Next 3Y11.43%
Revenue Next 5Y9.67%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BCO.DE Yearly Revenue VS EstimatesBCO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B
BCO.DE Yearly EPS VS EstimatesBCO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 -10 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. BCO.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BCO. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 595.61, BCO can be considered very expensive at the moment.
  • BCO's Price/Forward Earnings ratio is rather expensive when compared to the industry. BCO is more expensive than 82.14% of the companies in the same industry.
  • BCO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.80.
Industry RankSector Rank
PE N/A
Fwd PE 595.61
BCO.DE Price Earnings VS Forward Price EarningsBCO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCO.DE Per share dataBCO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • BCO's earnings are expected to grow with 41.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.63%
EPS Next 3Y41.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BCO.DE Dividend Analysis

5.1 Amount

  • BCO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BCO.DE Fundamentals: All Metrics, Ratios and Statistics

BOEING CO/THE

FRA:BCO (3/18/2026, 7:00:00 PM)

179.4

-3.2 (-1.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-27
Earnings (Next)04-21
Inst Owners73.74%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap140.89B
Revenue(TTM)89.46B
Net Income(TTM)1.89B
Analysts83.24
Price Target234.35 (30.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.38
Dividend Growth(5Y)-36.84%
DP17.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-118.5%
Min EPS beat(2)-179.06%
Max EPS beat(2)-57.93%
EPS beat(4)2
Avg EPS beat(4)-38.78%
Min EPS beat(4)-179.06%
Max EPS beat(4)63.2%
EPS beat(8)4
Avg EPS beat(8)-30.95%
EPS beat(12)6
Avg EPS beat(12)-17.74%
EPS beat(16)6
Avg EPS beat(16)-664.18%
Revenue beat(2)2
Avg Revenue beat(2)2.86%
Min Revenue beat(2)2.82%
Max Revenue beat(2)2.89%
Revenue beat(4)3
Avg Revenue beat(4)1.03%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)2.89%
Revenue beat(8)3
Avg Revenue beat(8)-1.65%
Revenue beat(12)5
Avg Revenue beat(12)-0.94%
Revenue beat(16)5
Avg Revenue beat(16)-3.25%
PT rev (1m)-0.5%
PT rev (3m)8.06%
EPS NQ rev (1m)7.49%
EPS NQ rev (3m)-1068.68%
EPS NY rev (1m)71.8%
EPS NY rev (3m)-83.83%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 595.61
P/S 1.82
P/FCF N/A
P/OCF 152.55
P/B 29.79
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.95
EYN/A
EPS(NY)0.3
Fwd EY0.17%
FCF(TTM)-2.08
FCFYN/A
OCF(TTM)1.18
OCFY0.66%
SpS98.79
BVpS6.02
TBVpS-14.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.11%
GM 4.79%
FCFM N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.1%
Cap/Sales 3.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.4
Altman-Z 1.32
F-Score6
WACC9.49%
ROIC/WACCN/A
Cap/Depr(3y)119.8%
Cap/Depr(5y)93.37%
Cap/Sales(3y)2.92%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
EPS Next Y103.37%
EPS Next 2Y56.63%
EPS Next 3Y41.46%
EPS Next 5Y26.39%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%
Revenue Next Year10%
Revenue Next 2Y12.26%
Revenue Next 3Y11.43%
Revenue Next 5Y9.67%
EBIT growth 1Y49.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year226.52%
EBIT Next 3Y75.47%
EBIT Next 5Y46.89%
FCF growth 1Y86.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.82%
OCF growth 3Y-32.82%
OCF growth 5YN/A

BOEING CO/THE / BCO.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BOEING CO/THE?

ChartMill assigns a fundamental rating of 2 / 10 to BCO.DE.


What is the valuation status for BCO stock?

ChartMill assigns a valuation rating of 1 / 10 to BOEING CO/THE (BCO.DE). This can be considered as Overvalued.


What is the profitability of BCO stock?

BOEING CO/THE (BCO.DE) has a profitability rating of 1 / 10.


Can you provide the financial health for BCO stock?

The financial health rating of BOEING CO/THE (BCO.DE) is 1 / 10.


Can you provide the dividend sustainability for BCO stock?

The dividend rating of BOEING CO/THE (BCO.DE) is 0 / 10 and the dividend payout ratio is 17.51%.